Skip to Main content Skip to Navigation
Journal articles

Control of lipolysis by natriuretic peptides and cyclic GMP.

Abstract : Human fat cell lipolysis was, until recently, thought to be mediated exclusively by a cAMP-dependent protein kinase (PKA)-regulated pathway under the control of catecholamines and insulin. We have shown that atrial- and B-type natriuretic peptides (ANP and BNP respectively) stimulate lipolysis in human fat cells through a cGMP-dependent protein kinase (PKG) signaling pathway independent of cAMP production and PKA activity. Pharmacological or physiological (exercise) increases in plasma ANP levels stimulate lipid mobilization in humans. This pathway becomes important during chronic treatment with beta-adrenoceptor antagonists, which inhibit catecholamine-induced lipolysis but enhance cardiac ANP release. These findings have metabolic implications and point to potential problems when natriuretic peptide secretion is altered or during therapeutic use of recombinant BNP.
Document type :
Journal articles
Complete list of metadata
Contributor : Marie Francoise Simon Connect in order to contact the contributor
Submitted on : Thursday, August 6, 2009 - 10:37:28 AM
Last modification on : Monday, July 4, 2022 - 9:47:43 AM

Links full text




Max Lafontan, Cédric Moro, Michel Berlan, François Crampes, Coralie Sengenes, et al.. Control of lipolysis by natriuretic peptides and cyclic GMP.. Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism , Elsevier, 2006, 19 (4), pp.130-7. ⟨10.1016/j.tem.2007.11.006⟩. ⟨inserm-00409147⟩



Record views